SPX3,719.04+71.75 1.97%
DIA296.62+5.43 1.86%
IXIC11,051.64+222.13 2.05%

Revive Therapeutics 宣布向 FDA 提交经修订的第 3 期 COVID-19研究协议

Revive Therapeutics 宣布向 FDA 提交经修订的第 3 期 COVID-19研究协议

MT Newswires · 09/14/2022 04:31

Please log in to view news